Items where authors include "Plant, D"

Article

Curry, PDK, Chinoy, H, Jani, M et al. (8 more authors) (2023) The impact of COVID-19 on medication adherence in a rheumatoid (BRAGGSS) and psoriatic arthritis (OUTPASS) UK cohort. The Journal of Rheumatology, 50 (7). jrheum.2022-1277. ISSN 0315-162X

Hum, RM, Ho, P, Nair, N et al. (8 more authors) (2023) Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. Rheumatology, 62 (6). pp. 2090-2097. ISSN 1462-0324

Smith, SL, Alexander, S, Nair, N et al. (8 more authors) (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Robinson, JI orcid.org/0000-0001-5425-7520, Md Yusof, MY orcid.org/0000-0003-3131-9121, Davies, V et al. (20 more authors) (2022) Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. eBioMedicine, 86. 104343. ISSN 2352-3964

Sutcliffe, M, Nair, N, Oliver, J et al. (9 more authors) (2022) Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy. Rheumatology, 61 (12). pp. 4935-4944. ISSN 1462-0324

Oliver, J, Nair, N, Orozco, G et al. (7 more authors) (2021) Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment. Arthritis Research & Therapy, 23 (1). 139. ISSN 1478-6354

Oliver, J, Nair, N, Orozco, G et al. (8 more authors) (2021) Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment. Arthritis Research & Therapy, 23 (1). 80. ISSN 1478-6354

Gilani, SSA, Nair, N, Plant, D et al. (8 more authors) (2020) Pharmacogenetics of TNFi Response in Rheumatoid Arthritis Utilising the Two-Component Disease Activity Score. The Pharmacogenomics Journal, 21 (16). ISSN 1470-269X

Dagliati, A, Plant, D, Nair, N et al. (10 more authors) (2020) Latent class trajectory modelling of 2‐components‐DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti‐rheumatic drugs. Arthritis & Rheumatology, 72 (10). pp. 1632-1642. ISSN 2326-5191

Nair, N, Plant, D, Verstappen, SM et al. (6 more authors) (2020) Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis. Rheumatology, 59 (6). pp. 1364-1371. ISSN 1462-0324

Spiliopoulou, A, Colombo, M, Plant, D et al. (12 more authors) (2019) Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39. Annals of the Rheumatic Diseases, 78 (8). pp. 1055-1061. ISSN 0003-4967

Cherlin, S, Plant, D, Taylor, JC orcid.org/0000-0002-2518-5799 et al. (11 more authors) (2018) Prediction of treatment response in Rheumatoid Arthritis patients using genome-wide SNP data. Genetic Epidemiology, 42 (8). pp. 754-771. ISSN 0741-0395

Massey, J, Plant, D, Hyrich, K et al. (10 more authors) (2018) Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis. The Pharmacogenomics Journal, 18. pp. 657-664. ISSN 1470-269X

Taylor, JC orcid.org/0000-0002-2518-5799, Bongartz, T, Massey, J et al. (37 more authors) (2018) Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients. The Pharmacogenomics Journal, 18 (4). pp. 528-538. ISSN 1470-269X

Smith, SL, Plant, D, Eyre, S et al. (5 more authors) (2017) The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort. Rheumatology, 56 (6). pp. 1019-1024. ISSN 1462-0324

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2016) Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. Rheumatology, 55 (11). pp. 2050-2055. ISSN 1462-0324

Plant, D, Webster, A, Nair, N et al. (9 more authors) (2016) Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis. Arthritis and Rheumatology, 68 (6). pp. 1353-1360. ISSN 2326-5191

Smith, SL, Plant, D, Lee, XH et al. (6 more authors) (2016) Previously reported PDE3A–SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort. Pharmacogenomics, 17 (7). pp. 715-720. ISSN 1462-2416

Bluett, J, Morgan, C, Thurston, L et al. (7 more authors) (2015) Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology, 54 (3). pp. 494-499. ISSN 1462-0324

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

Bluett, J, Ibrahim, I, Plant, D et al. (6 more authors) (2014) Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Pharmacogenomics Journal, 14 (2). pp. 171-175. ISSN 1470-269X

Plant, D, Ibrahim, I, Lunt, M et al. (8 more authors) (2012) Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Research and Therapy, 14 (5). R214. ISSN 1478-6354

Plant, D, Thomson, W, Lunt, M et al. (8 more authors) (2011) The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology, 50 (1). pp. 78-84. ISSN 1462-0324

Farragher, TM orcid.org/0000-0002-1968-6378, Plant, D, Flynn, E et al. (5 more authors) (2010) Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients. Arthritis Care and Research, 62 (5). pp. 676-682. ISSN 2151-464X

Farragher, TM orcid.org/0000-0002-1968-6378, Lunt, M, Plant, D et al. (3 more authors) (2010) Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. Arthritis Care and Research, 62 (5). pp. 664-675. ISSN 2151-464X

Conference or Workshop Item

Stadler, M, Ling, S, Nair, N et al. (7 more authors) (2021) Development of a Multivariable Prediction Model for Treatment Response to Etanercept in a Multi-centre Cohort of Patients with Established RA. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

David, T, Nair, N, Oliver, J et al. (8 more authors) (2021) POS0357 MiRNAs CORRELATE WITH IMPROVEMENT IN DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TUMOUR NECROSIS FACTOR INHIBITORS. In: EULAR 2021, 02-05 Jun 2021, Online.

Nair, N, Plant, D, Isaacs, J et al. (4 more authors) (2020) THU0022 DIFFERENTIAL DNA METHYLATION AS A PREDICTOR OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS. In: EULAR 2021, 02-05 Jun 2021, Online.